# ClinicalTrials.gov record NCT05669664

> PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct05669664-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05669664-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05669664-leuprolide-v1.json
- Content SHA-256: `d15f6a048acb1d3bd8ecee09dd64c02aa69caf734eaa3781d05c427793cb0b6b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05669664 ([`ctg-observation-nct05669664-2026-06-17-1cc9e92daca2`](#source-ctg-observation-nct05669664-2026-06-17-1cc9e92daca2))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct05669664-2026-06-17-1cc9e92daca2`](#source-ctg-observation-nct05669664-2026-06-17-1cc9e92daca2))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct05669664-2026-06-17-1cc9e92daca2`](#source-ctg-observation-nct05669664-2026-06-17-1cc9e92daca2))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05669664-2026-06-17-1cc9e92daca2`](#source-ctg-observation-nct05669664-2026-06-17-1cc9e92daca2))

## Sources

<a id="source-ctg-observation-nct05669664-2026-06-17-1cc9e92daca2"></a>
- **ClinicalTrials.gov record NCT05669664 · retained source version 2026-06-17:1cc9e92daca2e48442a97e4d66e5a7adcbabfa6fda01a0441097da551cf8d473** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05669664) (`ctg-observation-nct05669664-2026-06-17-1cc9e92daca2`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05669664." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05669664-leuprolide-v1.json SHA-256: d15f6a048acb1d3bd8ecee09dd64c02aa69caf734eaa3781d05c427793cb0b6b.